Table 1

Results of Synco-2D therapy for xenografted human ovarian cancer in the peritoneum

TreatmentNNo. of mice with tumorsNo. of nodulesTumor weight (g)aDeath rate
PBS88/82.5 ± 0.91.0 ± 0.68/8
Baco-188/81.0 ± 0.0b1.5 ± 0.73/8b
Synco-2D82/8c0.25 ± 0.4c0.1 ± 0.3c0/8c
  • a Means and SDs.

  • b P < 0.01 as compared with PBS control.

  • c P < 0.01 as compared with either the PBS- or Baco-1-treated group.